Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Chad Patterson, insider at DexCom
Chad Patterson Insider Alerts

Get notified the next time Chad Patterson buys or sells DexCom stock. Enter your email address below to get our daily insider buying and selling report.

Chad Patterson Insider Information

EVP of DexCom

Chad Patterson is Executive Vice President of Global Marketing at Dexcom.

In this role, Chad is responsible for global product management, design, clinical education, customer experience, research, public relations, and healthcare provider and direct-to-consumer marketing.

Since joining Dexcom in 2015, Chad has had multiple, successive positions of increased responsibility, including Senior Vice President, Global Marketing and Product Marketing. He established the direct-to-consumer and public relations functions for Dexcom and proceeded to build them into leaders in the industry.

Prior to Dexcom, Chad led marketing efforts for Nestlé both in Switzerland and the US on iconic brands such as Coffee-Mate, NESCAFÉ, Nesquik, Ovaltine, Cocoa, Carnation, Jamba Energy Drinks, and Hot Pockets.

Chad earned a Bachelor of Arts from Gonzaga University, where he played Division I soccer, and a Master of Business Administration from University of Southern California, Marshall School of Business.

How do I contact Chad Patterson?

The corporate mailing address for Mr. Patterson and other DexCom executives is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. DexCom can also be reached via phone at (858) 200-0200 and via email at [email protected]

Has Chad Patterson been buying or selling shares of DexCom?

Over the course of the past ninety days, Chad Patterson has sold $76,921.00 in shares of DexCom stock. Most recently, Chad Patterson sold 141 shares of the business's stock in a transaction on Wednesday, October 13th. The shares were sold at an average price of $545.54, for a transaction totalling $76,921.14.

Who are DexCom's active insiders?

DexCom's insider roster includes Nicholas Augustinos (Director), Andrew Balo (Insider), Quentin Blackford (COO), Richard Doubleday (EVP), Paul Flynn (EVP), Mark Foletta (Director), Jacob Leach (EVP), Patrick Murphy (EVP), Steven Pacelli (Insider), Chad Patterson (EVP), Kevin Sayer (CEO), Shelly Selvaraj (SVP), Sumi Shrishrimal (SVP), Jay Skyler (Director), and Jereme Sylvain (CAO).

Are insiders buying or selling shares of DexCom?

During the last twelve months, insiders at the medical device company sold shares 64 times. They sold a total of 226,679 shares worth more than $95,845,092.59. The most recent insider tranaction occured on December, 1st when Director Mark G Foletta sold 500 shares worth more than $281,415.00. Insiders at DexCom own 0.5 % of the company.

Information on this page was last updated on 12/1/2021.

Chad Patterson Insider Trading History at DexCom

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/13/2021Sell141$545.54$76,921.14View SEC Filing Icon  
9/9/2021Sell291$541.37$157,538.67View SEC Filing Icon  
See Full Table

Chad Patterson Buying and Selling Activity at DexCom

This chart shows Chad Patterson's buying and selling at DexCom by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DexCom Company Overview

DexCom logo
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $519.49
Low: $514.53
High: $561.07

50 Day Range

MA: $582.17
Low: $519.49
High: $651.26

2 Week Range

Now: $519.49
Low: $318.45
High: $659.45

Volume

1,436,107 shs

Average Volume

641,223 shs

Market Capitalization

$50.35 billion

P/E Ratio

99.33

Dividend Yield

N/A

Beta

0.8
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!